ICON has selected Wingspan Technology’s eTMF as its preferred system for paperless clinical trials. ICON has gone live with eTMF, a UAT ready, cloud-based Trial Master File system.

“We have seen tremendous growth in multi-company execution of clinical trials. Collaborations exist in every configuration – from sponsor-CRO to sponsor-sponsor to CRO-CRO and beyond. Wingspan TMF has been architected from the ground up to accelerate and enhance this new and dynamic business model and enable effective partnerships as never before,” said Rob Deming, director of strategy, planning and cloud services, Wingspan.

IO Biotech, a clinical-stage biopharma company developing immune modulating anti-cancer therapies, has entered into a collaborative agreement with Merck focused on the clinical evaluation of IO102 with KEYTRUDA (pembrolizumab) in non-small cell lung…